Basis: FMP quote market capitalization / book value attributable to common shareholders (matching reported total stockholders equity minus preferred stock). Source: stored company filings and market data; unavailable inputs remain N/A.
The P/B ratio is N/A as of 2026-10-06T13:35:27.668Z.
Calculation as of: 2026-10-06T13:35:27.668Z.
Quote observation: 2026-10-06T13:34:57.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: fdfad12185ff1a6c55ef1236bc2340ccae7aa6e4dec3824b1e7761c8ffaeec30
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-06-30.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PB RATIO
N/A
PB RATIO AVG TTM
N/A
PB RATIO AVG 3Y
N/A
PB RATIO AVG 5Y
N/A
PB RATIO AVG 10Y
N/A
PB RATIO AVG 15Y
N/A
PB RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$2.05B
PB Ratio
N/A
TTM Avg
68.48
3Y Avg
35.35
5Y Avg
46.14
Market Cap
$2.07B
PB Ratio
2.51
TTM Avg
2.74
3Y Avg
6.35
5Y Avg
12.27
Market Cap
$1.99B
PB Ratio
91.95
TTM Avg
116.97
3Y Avg
60.76
5Y Avg
121.33
| NAME | MARKET CAP | PB RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alvotech (ALVO) | $2.04B | N/A | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $2.05B | 1.35 | 0.82 | 1.06 | 1.61 |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.05B | N/A | 68.48 | 35.35 | 46.14 |
| Aurinia Pharmaceuticals Inc. (AUPH)vs › | $2.02B | 3.29 | 4.41 | 3.59 | 3.87 |
| AxoGen, Inc. (AXGN)vs › | $2.02B | 7.87 | 10.29 | 6.86 | 5.62 |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.07B | 2.51 | 2.74 | 6.35 | 12.27 |
| Absci Corporation (ABSI)vs › | $1.99B | 8.10 | 4.16 | 2.63 | 2.00 |
| Immunome, Inc. (IMNM)vs › | $1.99B | 3.79 | 5.14 | 7.43 | 5.74 |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.99B | 91.95 | 116.97 | 60.76 | 121.33 |
| Addus HomeCare Corporation (ADUS)vs › | $2.12B | 1.85 | 1.83 | 2.09 | 2.24 |
P/B Ratio
N/A
Market Price / Book Value per Share
PB Ratio = Market Cap / (Total Shareholders' Equity − Preferred Stock)
The price-to-book ratio compares market capitalization to book value attributable to common shareholders (total equity minus preferred stock). Lower values can indicate a cheaper valuation relative to net assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PB RATIO |
|---|---|
| 2022-06-30 | 8.77 |
| 2022-06-29 | 9.03 |
| 2022-06-28 | 9.59 |
| 2022-06-27 | 9.78 |
| 2022-06-24 | 9.44 |
| 2022-06-23 | 9.61 |
| 2022-06-21 | 1.36 |
| 2022-06-17 | 1.32 |
| 2022-06-16 | 1.53 |
